Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, Athenex, Daiichi Sankyo Inc, Genentech Inc, Genomic Health Inc, Lilly, Merck & Co Inc, Novartis Pharmaceuticals Corporation, Pfizer Inc, Puma Biotechnology Inc, and Seattle Genetics Inc.

For further information concerning Lilly grant funding, visit

Community Practice Connections™ 18th Annual International Congress on the Future of Breast Cancer™

Release Date: September 30, 2019
Expiration Date: September 30, 2020
Media: Internet - based

Activity Overview

Community Practice Connections™: 18th Annual International Congress on the Future of Breast Cancer™ features a review of recent clinical data guiding best practices in the treatment of patients with early-stage and advanced/metastatic breast cancer. Within the last few years, several new agents have entered the treatment armamentarium, and indications have expanded for others, resulting in continuously evolving treatment algorithms. The rapidity of these changes, combined with the volume of underlying data, creates challenges for practicing clinicians with regard to understanding how to best apply the emerging evidence to optimize outcomes for their patients. This educational activity is designed to update you on the latest data that have changed practice, or have the potential to change practice, for hormone receptor–positive, HER2-positive, and triple-negative breast cancers. In addition, this activity will explore the evolving utility of gene expression assays for guiding decision making in the clinic. Didactic summaries are accompanied by short video interviews with internationally recognized experts in the management of breast cancer. The video commentaries provide expert perspectives with regard to treatment decision points, clinical challenges, and questions commonly faced in community practice.

Benefits of Participating

  • Learn about the most recent clinical advances for patients with breast cancer.
  • Hear experts discuss how they apply the latest clinical data and updated treatment guidelines to the management of their patients with breast cancer.
  • Review strategies for individualizing treatment selection based on molecular biomarkers, patient comorbidities, and tumor-specific factors.
  • Learn best practices for monitoring and managing adverse events associated with novel therapeutic agents.
  • Gain awareness of new and emerging agents for the treatment of breast cancer, which may provide clinical trial opportunities for patients.

Acknowledgement of Commercial Support

This activity is supported by educational grants from AstraZeneca, Athenex, Daiichi Sankyo Inc, Genentech Inc, Genomic Health Inc, Lilly, Merck & Co Inc, Novartis Pharmaceuticals Corporation, Pfizer Inc, Puma Biotechnology Inc, and Seattle Genetics Inc.

For further information concerning Lilly grant funding, visit

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “Educational Content/Video” will be available for your reference.
  • In order to receive a CME Certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME Certificate upon completion of these steps.

Target Audience

This educational activity is directed toward medical, surgical, and radiation oncologists involved in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of breast cancer may also participate.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Individualize treatment planning for patients with breast cancer, integrating biomarker results and molecular and/or genomic assays as appropriate.
  • Review the latest advances and best practices in surgery and radiation therapy in order to optimize locoregional control in patients with early-stage or locally advanced breast cancer.
  • Integrate recent clinical trial results with systemic agents into personalized treatment strategies to optimize outcomes for patients with breast cancer.
  • Discuss the impact of emerging data regarding investigational approaches on evolving treatment paradigms for managing breast cancer.
  • Identify variances in care and planned/ongoing clinical trials that are evaluating investigational approaches in breast cancer treatment settings.

Faculty, Staff, and Planners’ Disclosures


Joyce A. O’Shaughnessy
Joyce A. O’Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor Charles A. Sammons Cancer Center
Texas Oncology
Co-Chair, Breast Cancer Research Program
The US Oncology Network
Dallas, TX

Disclosures: Consultant: AstraZeneca, Celgene, Lilly, Merck, Novartis, Pfizer, Seattle Genetics.

Charles E. Geyer Jr
Charles E. Geyer Jr, MD
Harrigan, Haw and Luck Families Chair in Cancer Research
Professor, Department of Internal Medicine
Division of Hematology, Oncology & Palliative Care
VCU School of Medicine/Massey Cancer Center
Richmond, VA

Disclosures: Other: AbbVie, AstraZeneca, Genentech/Roche-travel expenses, medical writing

Angela DeMichele
Angela DeMichele, MD, MSCE
Alan and Jill Miller Professor in Breast Cancer Excellence
Professor of Medicine and Epidemiology
Co-Leader, Breast Cancer Research Program
Abramson Cancer Center
Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA

Disclosures: Grant Research Support: Amgen, Daiichi, Genentech, Pfizer; Consultant: Novartis, Pfizer.

Joseph A. Sparano
Joseph A. Sparano, MD
Professor of Medicine and Obstetrics, Gynecology, and Women’s Health
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY

Disclosures: Grant Research Support: Deciphera, Prescient Therapeutics; Consultant: Adgero, AstraZeneca, Celldex, Eli Lilly, Genentech/Roche, Juno, Novartis, Pfizer; Shareholder: Metastats.

The staff of Physicians' Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only and is not meant to substitute for the independent clinical judgment of a physician and nurse relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of PER® or the company that provided commercial support for this program.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By